Literature DB >> 12145345

Cell type-specific expression and coregulation of murine resistin and resistin-like molecule-alpha in adipose tissue.

Michael W Rajala1, Ying Lin, Mollie Ranalletta, Xiao Man Yang, Hao Qian, Ron Gingerich, Nir Barzilai, Philipp E Scherer.   

Abstract

Adipocytes are the exclusive or predominant source of several secreted proteins that exert profound effects on systemic carbohydrate and lipid metabolism. Resistin, a 10-kDa adipose tissue specific secretory protein, has recently been implicated in exerting a negative effect on systemic insulin sensitivity. It is, however, not known how resistin mediates this insulin-desensitizing effect or what regulatory mechanisms control resistin expression. Resistin-like molecule-alpha (RELMalpha), a homolog of resistin originally identified by its upregulation in asthmatic lung, is another secreted protein expressed in adipose tissue. The regulation of RELMalpha in adipose tissue and its relationship to resistin expression has not been addressed so far. Here, we demonstrate that the expression of resistin and RELMalpha are similarly regulated in adipose tissue despite the fact that RELMalpha is exclusively expressed in the stromal vascular fraction of adipose tissue and not in adipocytes. Interestingly, this coregulation is limited to adipose tissue as the expression of RELMalpha in lung is independent of metabolic regulation. Additionally, we show that resistin and RELMalpha levels are not subject to regulation by proinflammatory stimuli. Finally, acute hyperglycemia leads to up-regulation of resistin and RELMalpha transcription in various adipose depots.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12145345     DOI: 10.1210/me.2002-0048

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  41 in total

1.  The irresistible biology of resistin.

Authors:  Gökhan S Hotamisligil
Journal:  J Clin Invest       Date:  2003-01       Impact factor: 14.808

2.  Adipose-derived resistin and gut-derived resistin-like molecule-beta selectively impair insulin action on glucose production.

Authors:  Michael W Rajala; Silvana Obici; Philipp E Scherer; Luciano Rossetti
Journal:  J Clin Invest       Date:  2003-01       Impact factor: 14.808

3.  Pathological Type-2 Immune Response, Enhanced Tumor Growth, and Glucose Intolerance in Retnlβ (RELMβ) Null Mice: A Model of Intestinal Immune System Dysfunction in Disease Susceptibility.

Authors:  Ingrid Wernstedt Asterholm; Ja Young Kim-Muller; Joseph M Rutkowski; Clair Crewe; Caroline Tao; Philipp E Scherer
Journal:  Am J Pathol       Date:  2016-07-07       Impact factor: 4.307

4.  Hyperresistinemia - a novel feature in systemic infection during human pregnancy.

Authors:  Shali Mazaki-Tovi; Edi Vaisbuch; Roberto Romero; Juan Pedro Kusanovic; Tinnakorn Chaiworapongsa; Sun Kwon Kim; Giovanna Ogge; Bo Hyun Yoon; Zhong Dong; Juan M Gonzalez; Maria Teresa Gervasi; Sonia S Hassan
Journal:  Am J Reprod Immunol       Date:  2010-02-18       Impact factor: 3.886

Review 5.  Human resistin: found in translation from mouse to man.

Authors:  Daniel R Schwartz; Mitchell A Lazar
Journal:  Trends Endocrinol Metab       Date:  2011-04-15       Impact factor: 12.015

6.  Regulation of insulin signalling, glucose uptake and metabolism in rat skeletal muscle cells upon prolonged exposure to resistin.

Authors:  R Palanivel; A Maida; Y Liu; G Sweeney
Journal:  Diabetologia       Date:  2005-12-09       Impact factor: 10.122

7.  Resistin-like molecule-α regulates IL-13-induced chemokine production but not allergen-induced airway responses.

Authors:  Ariel Munitz; Eric T Cole; Danielle Karo-Atar; Fred D Finkelman; Marc E Rothenberg
Journal:  Am J Respir Cell Mol Biol       Date:  2012-01-12       Impact factor: 6.914

8.  Insulin down-regulates resistin mRNA through the synthesis of protein(s) that could accelerate the degradation of resistin mRNA in 3T3-L1 adipocytes.

Authors:  J Kawashima; K Tsuruzoe; H Motoshima; A Shirakami; K Sakai; Y Hirashima; T Toyonaga; E Araki
Journal:  Diabetologia       Date:  2003-02-11       Impact factor: 10.122

9.  Role of resistin in diet-induced hepatic insulin resistance.

Authors:  Evan D Muse; Silvana Obici; Sanjay Bhanot; Brett P Monia; Robert A McKay; Michael W Rajala; Philipp E Scherer; Luciano Rossetti
Journal:  J Clin Invest       Date:  2004-07       Impact factor: 14.808

10.  Association of plasma levels of resistin with subcutaneous fat mass and markers of inflammation but not with metabolic determinants or insulin resistance.

Authors:  Jong Chul Won; Cheol-Young Park; Won Young Lee; Eon Sook Lee; Sang Woo Oh; Sung Woo Park
Journal:  J Korean Med Sci       Date:  2009-07-30       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.